Semi-Supervised Learning to Improve Generalizability of Cancer Associated-Venous Thromboembolism Risk Prediction Models

Read full text
Authors: Shuai Jin, Chong Wang, Dan Qin, Baosheng Liang, Lichuan Zhang, Weiyin Gao, Xiao Wang, Bo Jiang, Benqiang Rao, Hanping Shi, Lihui Liu, Qian Lu
Cited by: 1
References: 50

Abstract

Objective The purpose of this study is to develop and validate an improved CA-VTE risk prediction model based on semi-supervised learning (SSL) algorithm. Methods This study used a combined retrospective and prospective cohort design. First, data from 2100 cancer patients in a tertiary hospital in Beijing were retrospectively collected, including a “labeled cohort” with CA-VTE outcomes ( N = 1036) and an “unlabeled cohort” without outcomes ( N = 1064). Then, another dataset were prospectively collected as an external validation set ( N = 321). Eight supervised machine learning (ML) algorithms were used to develop CA-VTE risk prediction models and one SSL algorithm was used to improve generalizability of the models (pre- and post-imputation ML models). Model performance were evaluated using the Area Under the Curve (AUC) and Brier score in the prospective cohort, and compare them with the Khorana score. Results The eight post-imputation ML models (AUC: 0.816-0.868; Brier score: 0.118-0.160) performed better on the external validation set than the pre-imputation models (AUC: 0.798-0.841; Brier score: 0.133-0.171). In contrast, the AUC of the Khorana score remained unchanged (AUC: 0.693), while its Brier score increased (Brier score: 0.172 vs 0.178). Conclusion Based on a retrospective and prospective cohort study design, this study developed eight ML models that outperformed the Khorana score. Using SSL algorithm improved the external validation performance of the models and enhanced prediction accuracy. This study can provide an important reference for the early identification of high-risk factors and stratified preventive care for CA-VTE.

Fields of Study & Subjects

Venous Thromboembolism Diagnosis and Management Inflammatory Biomarkers in Disease Prognosis Diagnosis and Treatment of Venous Diseases

Publication details

Journal / source
Clinical and Applied Thrombosis/Hemostasis
Publisher
SAGE Publications
Volume
32
Pages
10760296261416914–10760296261416914
Publication date
1 January 2026
Language
EN